Cellino is using AI and machine learning to scale production of stem cell therapies
TechCrunch
SEPTEMBER 22, 2021
Cellino , a company developing a platform to automate stem cell production, presented today at TechCrunch Disrupt 2021 to detail how its system, which combines A.I. technology, machine learning, hardware, software — and yes, lasers! — could eventually democratize access to cell therapies.
Let's personalize your content